Centrafarm Services B.V. Remedica Ltd STADA Arzneimittel AG
PolandAll drugs from this manufacturer
-
Dasatinib Stada is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment has been ineffective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 20 mg ATC: L01EA02
-
The medicine is used for the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children aged 1 year and older, and for the treatment of acute lymphoblastic leukemia (ALL) with the presence of the Philadelphia chromosome (Ph+) in adults, adolescents, and children (from 1 year of age), as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment was ineffective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 50 mg ATC: L01EA02
-
The medicine is used for the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age, and for the treatment of acute lymphoblastic leukemia (ALL) with the presence of the Philadelphia chromosome (Ph+) in adults, adolescents, and children over 1 year of age, as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment was ineffective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 70 mg ATC: L01EA02
-
The medicinal product is used for the treatment of chronic myeloid leukemia in adults, adolescents and children (from 1 year of age) and for the treatment of acute lymphoblastic leukemia in adults, adolescents and children (from 1 year of age), as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment has been ineffective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 80 mg ATC: L01EA02
-
The medicine is used for the treatment of chronic myeloid leukemia in adults, adolescents and children (from 1 year of age) and for the treatment of acute lymphoblastic leukemia in adults, adolescents and children (from 1 year of age), as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment has been ineffective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 100 mg ATC: L01EA02
-
The medicine is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment has been ineffective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 140 mg ATC: L01EA02